Synthesis and antitumor activity of some new xanthotoxin derivatives. 2009

Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
Chemistry of Natural Product Department, National Research Center, Dokki, Cairo, Egypt. ommryan@yahoo.com

The condensation of 4-amino-9-methoxy psoralene (4-aminoxanthotoxin) with some aromatic aldehydes led to the formation of 4-arylimine xanthotoxin derivatives 2a-h, which were cyclized with mercaptoacetic acid to afford the thiazolidinone derivatives 3a-h. On the other hand, the reaction of aminoxanthotoxin 1 with some anhydrides afforded 4-imidione derivatives 3a-d. When 1 reacted with some isothiocyanates, the thiourea derivatives 5a-c were obtained but the thiourea derivative 6 was obtained when 1 reacted with ammonium thiocyanate. The thiourea derivative 6 was cyclized by the reaction with monochloroacetic acid in the presence of sodium acetate to give aminothiazolidinone derivative 7, but when the same reaction is carried out in the presence of pyridine, the thioxoimidazolidinone 8 was formed. The condensation of xanthotoxin sulphonamide with aromatic aldehydes gave the aryliminosulphonyl derivatives 9a-e. Xanthotoxin sulphonyl hydrazine condensed with some anhydride afforded sulphonic acid imide derivatives 10a-c. The antitumor and cytotoxic activities of 9 synthesized derivatives were tested, five compounds were found to be active, they inhibited the growth of HeLa cells.

UI MeSH Term Description Entries
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
June 2014, Archiv der Pharmazie,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
January 2011, Archiv der Pharmazie,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
August 1993, Archiv der Pharmazie,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
May 2001, Die Pharmazie,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
May 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
April 2009, European journal of medicinal chemistry,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
January 2012, Journal of Asian natural products research,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
January 1988, Journal of medicinal chemistry,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
September 1990, Die Pharmazie,
Omaima M Abdel Hafez, and Kamellia M Amin, and Nehad A Abdel-Latif, and Tahia K Mohamed, and Eman Y Ahmed, and Timothy Maher
December 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!